ArticleProtein & cell2025

A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignancies.

Lijun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.